Node way out

Survey of Ophthalmology

Volumn 45, Issue 1, 2000, Pages 77-83

  Vaphiades, Michael S ^a   Brown, Harry ^b   Whitcup, Scott M ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

Autoimmune retinopathy; Bipolar cells; Cancer associated retinopathy; Cone dysfunction; Electroretinogram; Melanoma associated retinopathy; Rod dysfunction; Visual hallucinations

Indexed keywords

CANCER ANTIBODY;

ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ELECTRORETINOGRAPHY; FEMALE; HALLUCINATION; HUMAN; IMMUNOLOGY; MELANOMA; MIDDLE AGED; NIGHT BLINDNESS; PARANEOPLASTIC SYNDROME; RETINA DISEASE; SKIN TUMOR; VISUAL ACUITY; VISUAL FIELD;

ANTIBODIES, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; ELECTRORETINOGRAPHY; FEMALE; HALLUCINATIONS; HUMANS; MELANOMA; MIDDLE AGED; NIGHT BLINDNESS; PARANEOPLASTIC SYNDROMES; RETINAL DISEASES; SKIN NEOPLASMS; VISUAL ACUITY; VISUAL FIELDS;

EID: 0034220726     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(00)00133-8     Document Type: Note

References (45)

1. Alexander KR, Fishman GA, Peachey NS, et al: Response defect in paraneoplastic night blindness with cutaneousmalignant melanoma. Invest Ophthalmol Vis Sci 33:477-83, 1992
2. Andreasson S, Ponjavic V, Ehinger B: Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy. Acta Ophthalmol 71:487-90, 1993
3. Aptsiauri N, Jordan BL, Heckenlively J: Anti-recoverin immunoreactivity in patients with retinal degeneration without systemic malignancy [abstract]. Invest Ophthalmol Vis Sci 39:5363, 1998
4. AraiJ, Kikuchi T, Katai N, et al: Tubby-like protein 1 is one of the retinal autoantigens in a patient with cancer-associated retinopathy [abstract]. Invest Ophthalmol Vis Sci 39:S724, 1998
5. Berson EL, Lessell S: Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 106:307-11, 1988.
6. Buchanan TAS, Gardiner TA, Archer DB: An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol 97:277-87, 1984.
7. Dalakas MC (ed): The use of intravenous immunoglobulin for neurologic diseases. Neurology 551:S1-S45, 1998
8. Foster CS, Ahmed AR: Intravenous Immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology 106:2136-43, 1999
9. Gehrs K, Tiedeman J: Hemeralopia in an older adult. Surv Ophthalmol 37:185-9, 1992
10. Grunwald GB, Klein R, Simmonds MA, Kornguth SE: Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Lancet 1:658-61, 1985
11. Grunwald GB, Kornguth SE, Towfighi J, et al: Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer 60:780-6, 1987
12. Guy J, Aptsiauri N: Treatment of paraneoplastic visual loss with intravenous immunoglobulin. Arch Ophthalmol 117:471-7, 1999
13. HeckenlivelyJR, Oversier JJ, Jordan BL, et al: CAR-like syndrome: Progressive panretinal degenerations not associated with cancer but with anti-recoverin (and other) anti-retinal antibodies [abstract]. Invest Ophthalmol Vis Sci 39:5216, 1998
14. Heckenlively JR, Jordan BL, Aptsiauri N: Associated of anti-retinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127:565-73, 1999
15. Jacobson DM: Paraneoplastic diseases of neuro-ophthalmologic interest, in Miller NR, Newman JN (eds): Walsh & Hoyt's Clinical Neuro-Ophthalmology. Baltimore, MD, Williams & Wilkins, 1998, pp 2497-551
16. Jordon BL, Dawson WW, Fang T, et al: Functional retinal abnormalities among cancer patients [abstract]. Invest Ophthalmol Vis Sci 39:5402, 1998
17. KeltnerJL, Thirkill CE: Cancer-associated retinopathy vs. recoverin-associated etinopathy [editorial]. Am J Ophthalmol 126:296-302, 1998
18. KeltnerJL, Thirkill CE: Commonality and diversity in the clinical and immune findings of melanoma-associated retinopathy (MAR) patients [abstract]. 24th Annual North American Neuro-Ophthalmology Society Meeting, Orlando, Florida, March 22, 1998, p 20
19. Keltner JL, Roth AM, Chang RS: Photoreceptor degeneration: possible autoimmune disorder. Arch Ophthalmol 101:564-9, 1983
20. Keltner JL, Thirkill CE, Tyler NK, Roth AM: Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol 110:48-53, 1992
21. Keltner JL, Thirkill CE: The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol 19:71-83, 1999
22. Kikuchi T, Arai J, Shibuki H, et al: Isolation and characterization of a new retinal and neuronal autoantigen recognized by serum of a patient with cancer-associated retinopathy [abstract]. Invest Ophthalmol Vis Sci 39:5724, 1998
23. Kim RY, Retsas S, Fitzke FW, et al: Cutaneous melanoma-associated retinopathy. Ophthalmology 101:1837-43, 1994
24. Kiratli H, Thirkill CE, Bilgif S, et al: Paraneoplastic retinopathy associated with metastic cutaneous melanoma of unknown primary site. Eye 11:889-92, 1997
25. Klingele TG, Burde RM, Rappazzo JA, et al: Paraneoplastic retinopathy. J Clin Neuro Ophthalmol 4:239-45, 1984
26. Kornguth SE, Klein R, Appen R, Choate J: Occurrence of antiretinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 50:1289-93, 1982
27. Kornguth SE, Kalinke T, Grunwald GB, et al: Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 46:2588-95, 1986
28. Machnicki DA, Fox DA, Adamus FG: Anti-recoverin antibody induces photoreceptor and bipolar cell apoptosis [abstract]. Invest Ophthalmol Vis Sci 39:5363, 1998
29. Merimsky O, Shoenfeld Y, Chaitchik S, et al: Antigens and antibodies in malignant melanoma. Tumour Biol 15:188-202, 1994
30. Milam AH, Saari JC, Jacobson SG, et al: Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34:91-100, 1993
31. MizenerJB, Kimura AE, Adamus G, et al: Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol 123:607-18, 1997
32. Ogawa KI, Maeda T, Ikeda Y, et al: Both 70kDa and 26 kDa proteins are autoantigens found in patients with cancer-associated retinopathy [abstract]. Invest Ophthalmol Vis Sci 39: S817, 1998
33. Okel BB, Thirkill CE, Anderson K: An unusual case of mela-noma-associated retinopathy. Ocular Immunol Inflam 3: 121-7, 1995
34. Pestronk, A: Paraneoplastic Neuropathies. Proceedings from the American Neurologic Association Annual Meeting, Montreal, Quebec, Canada, October 18-21, 1998
35. Potter MJ, Thirkill CE, Dam OM, et al: Clinical and Immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology 106:2121-5, 1999
36. Qureshi AI, Choudhry MA, Akbar MS, et al: Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 52:629-32, 1999
37. Remulla JFC, Pineda R, Gaudio AR, Milam AH: Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol 113:854-5, 1995
38. Ripps H, Carr RE, Siegel IM, Greenstein VC: Functional abnormalities in vincristine-induced night blindness. Invest Ophthalmol Vis Sci 25:787-94, 1984.
39. Rosenbaum JT, George RK, Gordon C: The treatment of refractory uveitis with intravenous immunoglobulin. Am J Ophthalmol 127:545-9, 1999
40. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF: Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606-13, 1976.
41. Singh AD, Milam AH, Shields CL, et al: Melanoma-associated retinopathy. Am J Ophthalmol 119:369-70, 1995
42. Thirkill CE, Roth AM, Keltner JL: Cancer-associated retinopathy. Arch Ophthalmol 105:372-5, 1987
43. Visser LH, Schmitz PIM, Meulstee J, et al: Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barre Syndrome Study Group. Neurology 53:598-604, 1999
44. Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE: Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology 101:1236-43, 1994
45. Whitcup SM, Vistica BP, Milam AH, et al: Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 126:230-7, 1998